Boston, MA, Nov 21 (Bernama-GLOBE NEWSWIRE) — Genomic medicine, also known as precision medicine, offers transformative opportunities to reshape health care and public health from a ‘one size fits all’ approach to one utilizing an individual’s genetic profile, informing their personalized care pathway from prevention and diagnosis, to treatment of diseases and the development of novel and more effective drugs. To help further genomic medicine’s global promise, the International Center for Genetic Disease (iCGD) at Brigham and Women’s Hospital (a founding member of the Mass General Brigham system) and Harvard Medical School, is launching a six-month nationwide program to train 100 physicians across the United Arab Emirates (UAE) in clinical genomic medicine and genetic counseling. This training program is implemented in collaboration with the Department of Health – Abu Dhabi and Khalifa University of Science and Technology. The comprehensive partnership between iCGD, Mass General Brigham, and the Department of Health – Abu Dhabi will help advance life sciences and health care outcomes across the globe while leveraging the advanced genomics capabilities of the Emirate.
With an emphasis on screening, diagnosis, and treatment of a wide spectrum of genetic conditions, clinicians will become deft with the necessary knowledge and skills to address genetic and genomic challenges in a clinical setting. Additionally, the program ensures the successful execution of the Emirati Genome Program, bringing precision medicine to the forefront of public health policy formulation and implementation across the UAE.
